Article Details

Phase 3 Brilaroxazine Long-Term Data in Schizophrenia Set for SIRS Congress | RVPH Stock News

Retrieved on: 2025-03-31 00:52:28

Tags for this article:

Click the tags to see associated articles and topics

Phase 3 Brilaroxazine Long-Term Data in Schizophrenia Set for SIRS Congress | RVPH Stock News. View article details on hiswai:

Excerpt

Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo